This inventor holds 1 USPTO granted patent. Top assignee: Beckman Research Institute, City of Hope. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Shizhen Emily Wang: Innovator in Breast Cancer Treatment
Introduction
Shizhen Emily Wang is a notable inventor based in Glendora, CA, who has made significant contributions to the field of cancer treatment. Her innovative work focuses on methods for treating breast cancer, showcasing her dedication to advancing medical science.
Latest Patents
Wang holds a patent for "Methods and compositions for treatment of breast cancer." This patent outlines methods for treating breast cancer in subjects by administering an effective amount of an inhibitor of miR-105 or miR-122. Additionally, it provides methods for determining the levels of these microRNAs in biological samples, which can indicate a subject's risk of developing breast cancer. This patent represents a crucial step in the fight against breast cancer, with the potential to improve patient outcomes.
Career Highlights
Wang is affiliated with City of Hope, a leading research and treatment center for cancer. Her work at this institution allows her to collaborate with other experts in the field and contribute to groundbreaking research aimed at improving cancer therapies.
Collaborations
Wang collaborates with Xiwei Wu, a fellow researcher, to further enhance their understanding and treatment of breast cancer. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Shizhen Emily Wang's innovative approaches to breast cancer treatment highlight her commitment to improving patient care through scientific research. Her contributions are paving the way for new therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
